Circulating regulatory T cells were absolutely decreased in dermatomyositis/polymyositis patients and restored by low-dose IL-2
Ann Rheum Dis
.
2021 Aug;80(8):e130.
doi: 10.1136/annrheumdis-2019-216246.
Epub 2019 Oct 14.
Authors
Sheng-Xiao Zhang
1
,
Jia Wang
1
,
He-Hua Sun
1
,
Jia-Qian Zhang
1
,
Guang-Ying Liu
1
,
Jing Luo
1
,
Pei-Feng He
2
,
Xiao-Feng Li
3
Affiliations
1
Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China.
2
Department of Medical Information Management, Shanxi Medical University, Taiyuan, China.
3
Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China lxf_9859@sxmu.edu.cn.
PMID:
31611221
DOI:
10.1136/annrheumdis-2019-216246
No abstract available
Keywords:
dermatomyositis; polymyositis; treatment.
Publication types
Letter
Comment
MeSH terms
Dermatomyositis* / drug therapy
Humans
Interleukin-2
Muscle, Skeletal
Polymyositis* / drug therapy
T-Lymphocytes, Regulatory
Substances
Interleukin-2